Fintel reports that on March 17, 2025, D. Boral Capital initiated coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. As of March 4, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results